ORAGENICS, INC. Basic Shares Outstanding (Weighted Average)
ORAGENICS, INC. (OGEN) reported Basic Shares Outstanding (Weighted Average) of 4.43 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- ORAGENICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 4.43M shares, a 505.15% increase year-over-year.
- ORAGENICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 4.30M shares, a 608.32% increase year-over-year.
- ORAGENICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 4.23M shares, a 532.65% increase year-over-year.
- ORAGENICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 1.56M shares, a 617.32% increase year-over-year.
- ORAGENICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 2.16M shares, a 877.24% increase from fiscal 2024.
- ORAGENICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 220.73K shares, a 90.19% decline from fiscal 2023.
- ORAGENICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 2.25M shares, a 11.97% increase from fiscal 2022.
- ORAGENICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 2.01M shares, a 3.40% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 4 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.43M shares 10-Q · filed 2026-08-13 | 4.39M shares 10-Q · filed 2026-08-13 | 4.32M shares derived: average of 3 quarters · filed 2026-08-13 | 3.63M shares derived: average of 4 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | 4.30M shares 10-Q · filed 2026-05-08 | 4.27M shares derived: average of 2 quarters · filed 2026-05-08 | 3.37M shares derived: average of 3 quarters · filed 2026-05-08 | 2.71M shares derived: average of 4 quarters · filed 2026-08-13 | |||||
| 2025-12-31 | 4.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 2.90M shares derived: average of 2 quarters · filed 2026-03-16 | 2.18M shares derived: average of 3 quarters · filed 2026-08-13 | 2.16M shares 10-K · filed 2026-03-16 | |||||
| 2025-09-30 | 1.56M shares 10-Q · filed 2025-11-07 | 1.15M shares derived: average of 2 quarters · filed 2026-08-13 | 1.46M shares 10-Q · filed 2025-11-07 | 892.31K shares derived: average of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | 731.82K shares 10-Q · filed 2026-08-13 | 677.80K shares 10-Q · filed 2026-08-13 | 669.44K shares derived: average of 3 quarters · filed 2026-08-13 | 556.48K shares derived: average of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | 607.21K shares 10-Q · filed 2026-05-08 | 18.22M shares 10-Q · filed 2025-05-09 | 638.25K shares derived: average of 2 quarters · filed 2026-05-08 | 498.03K shares derived: average of 3 quarters · filed 2026-05-08 | 411.27K shares derived: average of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | 669.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 443.45K shares derived: average of 2 quarters · filed 2026-03-16 | 345.95K shares derived: average of 3 quarters · filed 2026-03-16 | 220.73K shares 10-K · filed 2026-03-16 | 6.62M shares 10-K · filed 2025-03-14 | ||||
| 2024-09-30 | 217.60K shares 10-Q · filed 2025-11-07 | 6.53M shares 10-Q · filed 2024-11-13 | 184.28K shares derived: average of 2 quarters · filed 2025-11-07 | 71.21K shares 10-Q · filed 2025-11-07 | 4.86M shares 10-Q · filed 2024-11-13 | 1.61M shares derived: average of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | 150.97K shares 10-Q · filed 2025-08-08 | 4.53M shares 10-Q · filed 2024-08-09 | 133.75K shares 10-Q · filed 2025-08-08 | 4.01M shares 10-Q · filed 2024-08-09 | 2.08M shares derived: average of 3 quarters · filed 2025-08-08 | 2.15M shares derived: average of 4 quarters · filed 2025-08-08 | |||
| 2024-03-31 | 3.50M shares 10-Q · filed 2025-05-09 | 3.04M shares derived: average of 2 quarters · filed 2025-05-09 | 2.81M shares derived: average of 3 quarters · filed 2025-05-09 | 2.62M shares derived: average of 4 quarters · filed 2025-05-09 | |||||
| 2023-12-31 | 2.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | 2.47M shares derived: average of 2 quarters · filed 2025-03-14 | 2.32M shares derived: average of 3 quarters · filed 2025-03-14 | 2.25M shares 10-K · filed 2025-03-14 | |||||
| 2023-09-30 | 2.36M shares 10-Q · filed 2024-11-13 | 2.19M shares derived: average of 2 quarters · filed 2024-11-13 | 2.14M shares 10-Q · filed 2024-11-13 | 2.20M shares derived: average of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | 2.02M shares 10-Q · filed 2024-08-09 | 1.94M shares 10-Q · filed 2024-08-09 | 2.02M shares 10-Q · filed 2023-08-11 | 2.15M shares derived: average of 3 quarters · filed 2024-08-09 | 2.10M shares derived: average of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | 2.20M shares 10-Q · filed 2024-05-15 | 2.02M shares 10-Q · filed 2023-05-12 | 2.21M shares derived: average of 2 quarters · filed 2024-05-15 | 2.12M shares derived: average of 3 quarters · filed 2024-05-15 | 2.08M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 2.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 2.08M shares derived: average of 2 quarters · filed 2024-03-29 | 2.03M shares derived: average of 3 quarters · filed 2024-03-29 | 2.01M shares 10-K · filed 2024-03-29 | |||||
| 2022-09-30 | 1.95M shares 10-Q · filed 2023-11-09 | 116.74M shares 10-Q · filed 2022-11-14 | 1.94M shares derived: average of 2 quarters · filed 2023-11-09 | 1.94M shares 10-Q · filed 2023-11-09 | 116.51M shares 10-Q · filed 2022-11-14 | -80.40M shares derived: average of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | 1.94M shares 10-Q · filed 2023-08-11 | 116.39M shares 10-Q · filed 2022-08-09 | 116.39M shares 10-Q/A · filed 2023-04-14 | 1.94M shares 10-Q · filed 2023-08-11 | 116.39M shares 10-Q · filed 2022-08-09 | -107.84M shares derived: average of 3 quarters · filed 2023-08-11 | -51.82M shares derived: average of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | 2.00M shares 10-Q · filed 2023-05-12 | 116.39M shares 10-Q · filed 2022-05-13 | -162.74M shares derived: average of 2 quarters · filed 2023-05-12 | -69.74M shares derived: average of 3 quarters · filed 2023-05-12 | -23.34M shares derived: average of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -327.47M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17 | -105.61M shares derived: average of 2 quarters · filed 2023-04-17 | -31.78M shares derived: average of 3 quarters · filed 2023-04-17 | 1.94M shares 10-K · filed 2023-04-17 | 112.92M shares 10-K/A · filed 2022-07-29 | ||||
| 2021-09-30 | 116.26M shares 10-Q/A · filed 2023-04-14 | 116.06M shares derived: average of 2 quarters · filed 2023-04-14 | 111.75M shares 10-Q/A · filed 2023-04-14 | ||||||
| 2021-06-30 | 115.86M shares 10-Q/A · filed 2023-04-14 | 109.36M shares 10-Q/A · filed 2023-04-14 | |||||||
| 2021-03-31 | 102.97M shares 10-Q/A · filed 2023-04-14 | ||||||||
| 2020-12-31 | 56.53M shares 10-K/A · filed 2022-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |